Filter posts

USMCA Paves the Way for Biotech Innovation

After more than a year of high-stakes drama, the U.S. has inked an updated trade …

UN Proposals to Weaken IP Will Not Benefit Patients

Next week the 73rd session of the United Nations General Assembly (UNGA) will convene in …

Patents Are The Lifeblood of Biotechnology

Strong patents are the lifeblood of the biotechnology industry. They are critical in ensuring a …

Double Jeopardy at the PTO Threatens Healthcare Innovation

There has been no shortage of commentary related to the efforts of Allergan to shield …

Group of Inventors Burn Their Patents in Protest

As reported last week by IP Watchdog, the United States Patent and Trademark Office (PTO) …

Weak Patent Law Endangers Healthcare Innovation

Last week The Wall Street Journal published a fascinating expose that pulled back the curtain …

Panel Takes Look at Trump’s Trade Policy

Day three of the BIO International Convention brought some heavy hitters to the stage. From …

BIO Statement on SCOTUS Biosimilar Products Ruling

On Monday the United States Supreme Court issued a decision in Sandoz, Inc. v. Amgen, …

#BIO2017: What's Happening in the World of IP?

Who’s ready to hit the beach? Wait, did I say beach? I meant the San …

USTR’s Report Targets Trade Barriers to Biotech

The Office of the United States Trade Representative’s (USTR) annual Special 301 Report identifies trade …